According to a study of associated diagnosis of hepatocellular carcinoma (HCC), a high model for end-stage liver disease (MELD) score, advanced stage of the tumor, and increased level of alanine transaminase are poor prognostic factors and associated with a higher risk and both short- and long-term mortality [10]. The gene discussed is GPT; the disease is End Stage Liver Disease.